| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NVDA | Common Stock | Options Exercise | $1,446,520 | +400,000 | +7.7% | $3.62* | 5,583,192 | 02 Aug 2021 | Direct | F1, F2 |
| transaction | NVDA | Common Stock | Sale | $9,118,171 | -46,909 | -0.84% | $194.38 | 5,536,283 | 02 Aug 2021 | Direct | F1, F3 |
| transaction | NVDA | Common Stock | Sale | $8,775,493 | -44,938 | -0.81% | $195.28 | 5,491,345 | 02 Aug 2021 | Direct | F1, F4 |
| transaction | NVDA | Common Stock | Sale | $10,912,535 | -55,662 | -1% | $196.05 | 5,435,683 | 02 Aug 2021 | Direct | F1, F5 |
| transaction | NVDA | Common Stock | Sale | $16,550,411 | -83,842 | -1.5% | $197.40 | 5,351,841 | 02 Aug 2021 | Direct | F1, F6 |
| transaction | NVDA | Common Stock | Sale | $23,807,262 | -119,960 | -2.2% | $198.46 | 5,231,881 | 02 Aug 2021 | Direct | F1, F7 |
| transaction | NVDA | Common Stock | Sale | $9,692,032 | -48,689 | -0.93% | $199.06 | 5,183,192 | 02 Aug 2021 | Direct | F1, F8 |
| holding | NVDA | Common Stock | 62,565,496 | 02 Aug 2021 | By Trust | F2, F9, F10 | |||||
| holding | NVDA | Common Stock | 4,948,956 | 02 Aug 2021 | By Partnership | F2, F11 | |||||
| holding | NVDA | Common Stock | 2,986,630 | 02 Aug 2021 | The Lori Lynn Huang 2016 Annuity Trust II Agreement | F2, F9 | |||||
| holding | NVDA | Common Stock | 2,986,630 | 02 Aug 2021 | The Jen-Hsun Huang 2016 Annuity Trust II Agreement | F2, F9 | |||||
| holding | NVDA | Common Stock | 2,228,000 | 02 Aug 2021 | By Irrevocable Trust | F2, F12 | |||||
| holding | NVDA | Common Stock | 5,007,800 | 02 Aug 2021 | By Irrevocable Remainder Trust | F2, F13 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NVDA | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -400,000 | -67% | $0.000000 | 200,000 | 02 Aug 2021 | Common Stock | 400,000 | $3.62 | Direct | F1, F2, F14 |
| Id | Content |
|---|---|
| F1 | This transaction was pursuant to a 10b5-1 Plan, as adjusted to give effect to a four-for-one forward split of the Issuer's common stock in the form of a stock dividend distributed on July 19, 2021 (the "stock split"). |
| F2 | Adjusted to reflect the stock split. |
| F3 | Represents weighted average sales price. The shares were sold at prices ranging from $193.75 to $194.72. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F4 | Represents weighted average sales price. The shares were sold at prices ranging from $194.76 to $195.75. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F5 | Represents weighted average sales price. The shares were sold at prices ranging from $195.76 to $196.75. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F6 | Represents weighted average sales price. The shares were sold at prices ranging from $196.85 to $197.84. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F7 | Represents weighted average sales price. The shares were sold at prices ranging from $197.85 to $198.85. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F8 | Represents weighted average sales price. The shares were sold at prices ranging from $198.85 to $199.48. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F9 | As previously disclosed, on June 22, 2021, 2,930 pre-stock split shares of the Issuer's Common Stock held by The Lori Lynn Huang 2016 Annuity Trust II Agreement, and 2,930 pre-stock split shares of the Issuer's Common Stock held by The Jen-Hsun Huang 2016 Annuity Trust II Agreement were transferred for no consideration to the Jen-Hsun & Lori Huang Living Trust, u/a/d May 1, 1995 to satisfy annuity payments (collectively, the "GRAT transfer shares"). Additional shares issued in connection with the stock split with respect to the GRAT transfer shares were delivered to The Lori Lynn Huang 2016 Annuity Trust II Agreement and The Jen-Hsun Huang 2016 Annuity Trust II Agreement. |
| F10 | The shares are held by Jen-Hsun Huang and Lori Huang, as co-trustees of the Jen-Hsun & Lori Huang Living Trust, u/a/d May 1, 1995 (the "Trust"), of which the Reporting Person is a trustee. |
| F11 | The shares are held by J. and L. Huang Investments, L.P., of which the Trust is the general partner. |
| F12 | The shares are held by The Huang 2012 Irrevocable Trust, of which the Reporting Person is a trustee. |
| F13 | The shares are held by The Huang Irrevocable Remainder Trust u/a/d February 19, 2016, of which the Reporting Person is a trustee. |
| F14 | Fully vested. |